Shareholders' equity · 2011–2025
Sinovac Biotech shareholders' equity
$4.4B−46.3% · FY2025
Sinovac Biotech (SVA) reported $4.4B in shareholders' equity for fiscal 2025, −46.3% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $4.4B | −46.3% | Open → |
| FY20242024-12-31 | $8.3B | −0.6% | Open → |
| FY20232023-12-31 | $8.3B | −2.1% | Open → |
| FY20222022-12-31 | $8.5B | −5.6% | Open → |
| FY20212021-12-31 | $9.0B | +1,105.0% | Open → |
| FY20202020-12-31 | $746M | +153.9% | Open → |
| FY20192019-12-31 | $294M | +16.0% | Open → |
| FY20182018-12-31 | $253M | +67.7% | Open → |
| FY20172017-12-31 | $151M | +30.6% | Open → |
| FY20162016-12-31 | $116M | −4.8% | Open → |
| FY20152015-12-31 | $122M | −3.9% | Open → |
| FY20142014-12-31 | $127M | −1.6% | Open → |
| FY20132013-12-31 | $129M | +9.3% | Open → |
| FY20122012-12-31 | $118M | −9.4% | Open → |
| FY20112011-12-31 | $130M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +28.7%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Sinovac Biotech shareholders' equity |url=https://companiesranked.com/en/company/sinovac-biotech/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Sinovac Biotech shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/sinovac-biotech/shareholders-equityBibTeX
@misc{companiesranked-en-company-sinovac-biotech-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Sinovac Biotech shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/sinovac-biotech/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001193125-26-258534 · June 5, 2026
{{cite web |title=Sinovac Biotech shareholders' equity — 20-F (0001193125-26-258534) |url=https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-06-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.